• Xeris Biopharma will release second-quarter 2026 financial results before the U.S. market opens on Aug. 6, 2026.
• Management will host a conference call and webcast at 8:30 a.m. ET on Aug. 6, 2026; registration via https://events.q4inc.com/attendee/250146676.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607230730BIZWIRE_USPR_____20260723_BW610212) on July 23, 2026, and is solely responsible for the information contained therein.